BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tomaro-Duchesneau C, Saha S, Malhotra M, Jones ML, Labbé A, Rodes L, Kahouli I, Prakash S. Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats. Appl Microbiol Biotechnol. 2014;98:115-126. [PMID: 24121931 DOI: 10.1007/s00253-013-5252-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol 2014; 20(43): 16079-16094 [PMID: 25473159 DOI: 10.3748/wjg.v20.i43.16079] [Cited by in CrossRef: 236] [Cited by in F6Publishing: 193] [Article Influence: 29.5] [Reference Citation Analysis]
2 Westfall S, Lomis N, Prakash S. Ferulic Acid Produced by Lactobacillus fermentum Influences Developmental Growth Through a dTOR-Mediated Mechanism. Mol Biotechnol 2019;61:1-11. [DOI: 10.1007/s12033-018-0119-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
3 Razmpoosh E, Javadi M, Ejtahed H, Mirmiran P. Probiotics as beneficial agents in the management of diabetes mellitus: a systematic review: Probiotics and Diabetes. Diabetes Metab Res Rev 2016;32:143-68. [DOI: 10.1002/dmrr.2665] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
4 Mukdsi MA, Argañaraz Martínez E, Chaia AP, Medina R. Feruloyl esterase activity is influenced by bile, probiotic intestinal adhesion and milk fat. Beneficial Microbes 2016;7:597-607. [DOI: 10.3920/bm2015.0197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Feng RN, Du SS, Wang C, Li YC, Liu LY, Guo FC, Sun CH. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World J Gastroenterol 2014; 20(47): 17932-17940 [PMID: 25548491 DOI: 10.3748/wjg.v20.i47.17932] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 92] [Article Influence: 12.9] [Reference Citation Analysis]
6 Zhao X, Zhong X, Liu X, Wang X, Gao X. Therapeutic and Improving Function of Lactobacilli in the Prevention and Treatment of Cardiovascular-Related Diseases: A Novel Perspective From Gut Microbiota. Front Nutr 2021;8:693412. [PMID: 34164427 DOI: 10.3389/fnut.2021.693412] [Reference Citation Analysis]
7 Ding YH, Qian LY, Pang J, Lin JY, Xu Q, Wang LH, Huang DS, Zou H. The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy. Oncotarget 2017;8:59915-28. [PMID: 28938693 DOI: 10.18632/oncotarget.18346] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
8 Feng T, Wang J. Oxidative stress tolerance and antioxidant capacity of lactic acid bacteria as probiotic: a systematic review. Gut Microbes 2020;12:1801944. [PMID: 32795116 DOI: 10.1080/19490976.2020.1801944] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
9 Sivamaruthi B, Kesika P, Chaiyasut C. Thai Fermented Foods as a Versatile Source of Bioactive Microorganisms—A Comprehensive Review. Sci Pharm 2018;86:37. [DOI: 10.3390/scipharm86030037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
10 Abboud M, Rizk R, AlAnouti F, Papandreou D, Haidar S, Mahboub N. The Health Effects of Vitamin D and Probiotic Co-Supplementation: A Systematic Review of Randomized Controlled Trials. Nutrients 2020;13:E111. [PMID: 33396898 DOI: 10.3390/nu13010111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Ma L, Zheng A, Ni L, Wu L, Hu L, Zhao Y, Fu Z, Ni Y. Bifidobacterium animalis subsp. lactis lkm512 Attenuates Obesity-Associated Inflammation and Insulin Resistance Through the Modification of Gut Microbiota in High-Fat Diet-Induced Obese Mice. Mol Nutr Food Res 2021;:e2100639. [PMID: 34847296 DOI: 10.1002/mnfr.202100639] [Reference Citation Analysis]
12 Finelli C, Tarantino G. Non-alcoholic fatty liver disease, diet and gut microbiota. EXCLI J 2014;13:461-90. [PMID: 26417275] [Reference Citation Analysis]
13 Montgomery MK, Turner N. Mitochondrial dysfunction and insulin resistance: an update. Endocr Connect 2015;4:R1-R15. [PMID: 25385852 DOI: 10.1530/EC-14-0092] [Cited by in Crossref: 283] [Cited by in F6Publishing: 154] [Article Influence: 35.4] [Reference Citation Analysis]
14 de Oliveira Y, Cavalcante RGS, Cavalcanti Neto MP, Magnani M, Braga VA, de Souza EL, de Brito Alves JL. Oral administration of Lactobacillus fermentum post-weaning improves the lipid profile and autonomic dysfunction in rat offspring exposed to maternal dyslipidemia. Food Funct 2020;11:5581-94. [PMID: 32524104 DOI: 10.1039/d0fo00514b] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
15 Russo M, Marquez A, Abeijón-Mukdsi MC, Santacruz A, López-Malo A, Gauffin-Cano P, Medina R. Microencapsulated feruloyl esterase-producing lactobacilli ameliorate lipid profile and glycaemia in high fat diet-induced obese mice. Benef Microbes 2019;10:189-98. [PMID: 30525955 DOI: 10.3920/BM2018.0025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
16 Sivamaruthi BS, Kesika P, Suganthy N, Chaiyasut C. A Review on Role of Microbiome in Obesity and Antiobesity Properties of Probiotic Supplements. Biomed Res Int 2019;2019:3291367. [PMID: 31211135 DOI: 10.1155/2019/3291367] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 15.3] [Reference Citation Analysis]
17 Xavier-santos D, Bedani R, Lima ED, Saad SMI. Impact of probiotics and prebiotics targeting metabolic syndrome. Journal of Functional Foods 2020;64:103666. [DOI: 10.1016/j.jff.2019.103666] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 6.5] [Reference Citation Analysis]
18 Tomaro-Duchesneau C, Jones ML, Shah D, Jain P, Saha S, Prakash S. Cholesterol assimilation by Lactobacillus probiotic bacteria: an in vitro investigation. Biomed Res Int 2014;2014:380316. [PMID: 25295259 DOI: 10.1155/2014/380316] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 6.5] [Reference Citation Analysis]
19 Berkes E, Liao YH, Neef D, Grandalski M, Monsul N. Potentiated In Vitro Probiotic Activities of Lactobacillus fermentum LfQi6 Biofilm Biomass Versus Planktonic Culture. Probiotics Antimicrob Proteins 2020;12:1097-114. [PMID: 31828607 DOI: 10.1007/s12602-019-09624-8] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Iqbal UH, Westfall S, Prakash S. Novel microencapsulated probiotic blend for use in metabolic syndrome: design and in-vivo analysis. Artif Cells Nanomed Biotechnol 2018;46:S116-24. [PMID: 30033770 DOI: 10.1080/21691401.2018.1489270] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
21 Gu C, Zhou W, Wang W, Xiang H, Xu H, Liang L, Sui H, Zhan L, Lu X. ZiBuPiYin recipe improves cognitive decline by regulating gut microbiota in Zucker diabetic fatty rats. Oncotarget 2017;8:27693-703. [PMID: 28099913 DOI: 10.18632/oncotarget.14611] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
22 Zhao X, Oduro PK, Tong W, Wang Y, Gao X, Wang Q. Therapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota. Pharmacol Res 2021;163:105362. [PMID: 33285231 DOI: 10.1016/j.phrs.2020.105362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Molina-Tijeras JA, Diez-Echave P, Vezza T, Hidalgo-García L, Ruiz-Malagón AJ, Rodríguez-Sojo MJ, Romero M, Robles-Vera I, García F, Plaza-Diaz J, Olivares M, Duarte J, Rodríguez-Cabezas ME, Rodríguez-Nogales A, Gálvez J. Lactobacillus fermentum CECT5716 ameliorates high fat diet-induced obesity in mice through modulation of gut microbiota dysbiosis. Pharmacol Res 2021;167:105471. [PMID: 33529749 DOI: 10.1016/j.phrs.2021.105471] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Çiftci G, Tuna E. Effects of cholesterol and Lactobacillus acidophilus on testicular function. Clin Exp Reprod Med 2021;48:229-35. [PMID: 34488287 DOI: 10.5653/cerm.2020.04322] [Reference Citation Analysis]
25 Wang J, Zhang W, Wang S, Wang Y, Chu X, Ji H. Lactobacillus plantarum Exhibits Antioxidant and Cytoprotective Activities in Porcine Intestinal Epithelial Cells Exposed to Hydrogen Peroxide. Oxid Med Cell Longev 2021;2021:8936907. [PMID: 34373770 DOI: 10.1155/2021/8936907] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Kahouli I, Malhotra M, Westfall S, Alaoui-Jamali MA, Prakash S. Design and validation of an orally administrated active L. fermentum-L. acidophilus probiotic formulation using colorectal cancer Apc Min/+ mouse model. Appl Microbiol Biotechnol. 2017;101:1999-2019. [PMID: 27837314 DOI: 10.1007/s00253-016-7885-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
27 Russo M, Fabersani E, Abeijón-Mukdsi MC, Ross R, Fontana C, Benítez-Páez A, Gauffin-Cano P, Medina RB. Lactobacillus fermentum CRL1446 Ameliorates Oxidative and Metabolic Parameters by Increasing Intestinal Feruloyl Esterase Activity and Modulating Microbiota in Caloric-Restricted Mice. Nutrients 2016;8:E415. [PMID: 27399766 DOI: 10.3390/nu8070415] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
28 Fijan S. Microorganisms with claimed probiotic properties: an overview of recent literature. Int J Environ Res Public Health. 2014;11:4745-4767. [PMID: 24859749 DOI: 10.3390/ijerph110504745] [Cited by in Crossref: 327] [Cited by in F6Publishing: 243] [Article Influence: 40.9] [Reference Citation Analysis]
29 Tarantino G, Finelli C. Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease. Future Microbiol. 2015;10:889-902. [PMID: 26000656 DOI: 10.2217/fmb.15.13] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 11.8] [Reference Citation Analysis]
30 Cabello-Olmo M, Oneca M, Torre P, Sainz N, Moreno-Aliaga MJ, Guruceaga E, Díaz JV, Encio IJ, Barajas M, Araña M. A Fermented Food Product Containing Lactic Acid Bacteria Protects ZDF Rats from the Development of Type 2 Diabetes. Nutrients 2019;11:E2530. [PMID: 31635188 DOI: 10.3390/nu11102530] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
31 Sun Z, Sun X, Li J, Li Z, Hu Q, Li L, Hao X, Song M, Li C. Using probiotics for type 2 diabetes mellitus intervention: Advances, questions, and potential. Crit Rev Food Sci Nutr. 2019;1-14. [PMID: 30632770 DOI: 10.1080/10408398.2018.1547268] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
32 Rivero-Gutiérrez B, Gámez-Belmonte R, Suárez MD, Lavín JL, Aransay AM, Olivares M, Martínez-Augustin O, Sánchez de Medina F, Zarzuelo A. A synbiotic composed of Lactobacillus fermentum CECT5716 and FOS prevents the development of fatty acid liver and glycemic alterations in rats fed a high fructose diet associated with changes in the microbiota. Mol Nutr Food Res 2017;61. [PMID: 28463404 DOI: 10.1002/mnfr.201600622] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
33 Gérard P. Gut microbiota and obesity. Cell Mol Life Sci 2016;73:147-62. [PMID: 26459447 DOI: 10.1007/s00018-015-2061-5] [Cited by in Crossref: 203] [Cited by in F6Publishing: 173] [Article Influence: 29.0] [Reference Citation Analysis]
34 Paulino do Nascimento LC, Lacerda DC, Ferreira DJS, de Souza EL, de Brito Alves JL. Limosilactobacillus fermentum, Current Evidence on the Antioxidant Properties and Opportunities to be Exploited as a Probiotic Microorganism. Probiotics Antimicrob Proteins 2022. [PMID: 35467236 DOI: 10.1007/s12602-022-09943-3] [Reference Citation Analysis]
35 Arora A, Behl T, Sehgal A, Singh S, Sharma N, Bhatia S, Sobarzo-Sanchez E, Bungau S. Unravelling the involvement of gut microbiota in type 2 diabetes mellitus. Life Sci 2021;273:119311. [PMID: 33662428 DOI: 10.1016/j.lfs.2021.119311] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
36 Ichim TE, Patel AN, Shafer KA. Experimental support for the effects of a probiotic/digestive enzyme supplement on serum cholesterol concentrations and the intestinal microbiome. J Transl Med 2016;14:184. [PMID: 27333764 DOI: 10.1186/s12967-016-0945-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
37 García-García FJ, Monistrol-Mula A, Cardellach F, Garrabou G. Nutrition, Bioenergetics, and Metabolic Syndrome. Nutrients 2020;12:E2785. [PMID: 32933003 DOI: 10.3390/nu12092785] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
38 Salazar N, López P, Garrido P, Moran J, Cabello E, Gueimonde M, Suárez A, González C, de los Reyes-Gavilán CG, Ruas-Madiedo P. Immune modulating capability of two exopolysaccharide-producing Bifidobacterium strains in a Wistar rat model. Biomed Res Int 2014;2014:106290. [PMID: 24971309 DOI: 10.1155/2014/106290] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
39 Chan YK, Brar MS, Kirjavainen PV, Chen Y, Peng J, Li D, Leung FC, El-Nezami H. High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE-/- mice. BMC Microbiol 2016;16:264. [PMID: 27821063 DOI: 10.1186/s12866-016-0883-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
40 Fabersani E, Russo M, Marquez A, Abeijón-Mukdsi C, Medina R, Gauffin-Cano P. Modulation of intestinal microbiota and immunometabolic parameters by caloric restriction and lactic acid bacteria. Food Res Int 2019;124:188-99. [PMID: 31466639 DOI: 10.1016/j.foodres.2018.06.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
41 Russo M, Marquez A, Herrera H, Abeijon-mukdsi C, Saavedra L, Hebert E, Gauffin-cano P, Medina R. Oral administration of Lactobacillus fermentum CRL1446 improves biomarkers of metabolic syndrome in mice fed a high-fat diet supplemented with wheat bran. Food Funct 2020;11:3879-94. [DOI: 10.1039/d0fo00730g] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]